Five months after the matter was seemingly closed, a lawsuit fighting to make Prince Harry’s private US visa records public ...

Athena Stavrou, The Independent Five months after the matter was seemingly closed, a lawsuit fighting to make Prince Harry’s ...

On January 17, the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) jointly published two final ...

The case to make the Duke’s visa application public has reopened, and with the President as an adversary he could be shown the door ...

A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted all-cause mortality among veterans treated at the VHA.

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

Catherine, Princess of Wales, has since shared that she completed treatment and is now in remission. She's also recently taken on some public royal duties after pausing them for several months due ...

A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...